| scholarly article | Q13442814 |
| P50 | author | Shou-Jiang Gao | Q41839530 |
| P2093 | author name string | Jie Qin | |
| Chun Lu | |||
| Wan Li | |||
| P2860 | cites work | Identification of cellular genes targeted by KSHV-encoded microRNAs | Q21131610 |
| TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencing | Q24320260 | ||
| Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells | Q24555724 | ||
| Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines | Q24594085 | ||
| MicroRNA targeting specificity in mammals: determinants beyond seed pairing | Q24607724 | ||
| A viral microRNA functions as an orthologue of cellular miR-155 | Q24652947 | ||
| The impact of microRNAs on protein output | Q24653549 | ||
| Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155 | Q24681400 | ||
| Cell Cycle Regulatory Functions of the KSHV Oncoprotein LANA | Q26749612 | ||
| Current State of Circulating MicroRNAs as Cancer Biomarkers | Q26796328 | ||
| Mammalian microRNAs predominantly act to decrease target mRNA levels | Q27860535 | ||
| A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA | Q27860813 | ||
| Widespread changes in protein synthesis induced by microRNAs | Q27860886 | ||
| Biogenesis of small RNAs in animals | Q27861013 | ||
| Small RNA profiling reveals antisense transcription throughout the KSHV genome and novel small RNAs | Q42727360 | ||
| Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells | Q47978435 | ||
| Potent effect of target structure on microRNA function. | Q52678484 | ||
| High conservation of Kaposi sarcoma--associated herpesvirus microRNAs implies important function | Q79687919 | ||
| Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans | Q28131807 | ||
| Upregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stress | Q28472699 | ||
| miR-K12-7-5p encoded by Kaposi's sarcoma-associated herpesvirus stabilizes the latent state by targeting viral ORF50/RTA | Q28476790 | ||
| Proteomic screening of human targets of viral microRNAs reveals functions associated with immune evasion and angiogenesis | Q28536884 | ||
| Specificity of microRNA target selection in translational repression | Q28776123 | ||
| Identification of microRNAs of the herpesvirus family | Q29618671 | ||
| The SH3BGR/STAT3 Pathway Regulates Cell Migration and Angiogenesis Induced by a Gammaherpesvirus MicroRNA. | Q30008930 | ||
| In-depth analysis of Kaposi's sarcoma-associated herpesvirus microRNA expression provides insights into the mammalian microRNA-processing machinery | Q33558454 | ||
| Pivotal advance: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes | Q33571183 | ||
| Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA | Q33625562 | ||
| A human herpesvirus microRNA inhibits p21 expression and attenuates p21-mediated cell cycle arrest | Q33826818 | ||
| Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus | Q33883910 | ||
| Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway | Q34092628 | ||
| A systems biology approach identified different regulatory networks targeted by KSHV miR-K12-11 in B cells and endothelial cells | Q34100180 | ||
| Kaposi sarcoma (KS)-associated herpesvirus microRNA sequence analysis and KS risk in a European AIDS-KS case control study. | Q34101588 | ||
| Kaposi's sarcoma herpesvirus microRNAs target caspase 3 and regulate apoptosis | Q34102689 | ||
| MicroRNAs encoded by Kaposi's sarcoma-associated herpesvirus regulate viral life cycle. | Q34166899 | ||
| Kaposi's sarcoma herpesvirus microRNAs induce metabolic transformation of infected cells | Q34257830 | ||
| Regulation of tumor necrosis factor-like weak inducer of apoptosis receptor protein (TWEAKR) expression by Kaposi's sarcoma-associated herpesvirus microRNA prevents TWEAK-induced apoptosis and inflammatory cytokine expression | Q34291063 | ||
| KSHV miRNAs decrease expression of lytic genes in latently infected PEL and endothelial cells by targeting host transcription factors | Q34423454 | ||
| MicroRNA-mediated transformation by the Kaposi's sarcoma-associated herpesvirus Kaposin locus | Q34453771 | ||
| A microRNA encoded by Kaposi sarcoma-associated herpesvirus promotes B-cell expansion in vivo | Q34490029 | ||
| Kaposi's sarcoma-associated herpesvirus fusion-entry receptor: cystine transporter xCT. | Q34507156 | ||
| A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses | Q34547697 | ||
| The role of GW/P-bodies in RNA processing and silencing | Q34578258 | ||
| Individual microRNAs (miRNAs) display distinct mRNA targeting "rules" | Q34581040 | ||
| A novel assay for viral microRNA function identifies a single nucleotide polymorphism that affects Drosha processing | Q34648273 | ||
| Kaposi's sarcoma-associated herpesvirus ORF57 promotes escape of viral and human interleukin-6 from microRNA-mediated suppression | Q34742851 | ||
| Viral microRNA target allows insight into the role of translation in governing microRNA target accessibility | Q34750228 | ||
| Systemically circulating viral and tumor-derived microRNAs in KSHV-associated malignancies. | Q34845533 | ||
| KSHV microRNAs mediate cellular transformation and tumorigenesis by redundantly targeting cell growth and survival pathways | Q35079842 | ||
| A Kaposi's sarcoma-associated herpesvirus-encoded ortholog of microRNA miR-155 induces human splenic B-cell expansion in NOD/LtSz-scid IL2Rγnull mice | Q35382266 | ||
| Kaposi's sarcoma-associated herpesvirus microRNAs repress breakpoint cluster region protein expression, enhance Rac1 activity, and increase in vitro angiogenesis | Q35641026 | ||
| Kaposi's sarcoma-associated herpesvirus-encoded microRNA miR-K12-11 attenuates transforming growth factor beta signaling through suppression of SMAD5. | Q35689725 | ||
| KSHV MicroRNAs Repress Tropomyosin 1 and Increase Anchorage-Independent Growth and Endothelial Tube Formation | Q35742729 | ||
| Direct and efficient cellular transformation of primary rat mesenchymal precursor cells by KSHV | Q35780222 | ||
| A KSHV microRNA Directly Targets G Protein-Coupled Receptor Kinase 2 to Promote the Migration and Invasion of Endothelial Cells by Inducing CXCR2 and Activating AKT Signaling | Q35786739 | ||
| A human herpesvirus miRNA attenuates interferon signaling and contributes to maintenance of viral latency by targeting IKKε. | Q35885525 | ||
| A KSHV microRNA enhances viral latency and induces angiogenesis by targeting GRK2 to activate the CXCR2/AKT pathway | Q35983671 | ||
| An Oncogenic Virus Promotes Cell Survival and Cellular Transformation by Suppressing Glycolysis | Q36019773 | ||
| Virus-Mediated Alterations in miRNA Factors and Degradation of Viral miRNAs by MCPIP1. | Q36205470 | ||
| Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma | Q36291986 | ||
| Kaposi's sarcoma-associated herpesvirus microRNAs target IRAK1 and MYD88, two components of the toll-like receptor/interleukin-1R signaling cascade, to reduce inflammatory-cytokine expression | Q36363240 | ||
| MicroRNAs and unusual small RNAs discovered in Kaposi's sarcoma-associated herpesvirus virions | Q36397498 | ||
| Emerging themes from EBV and KSHV microRNA targets | Q36404184 | ||
| Kaposi's sarcoma-associated herpesviral IL-6 and human IL-6 open reading frames contain miRNA binding sites and are subject to cellular miRNA regulation | Q36483206 | ||
| Human Mesenchymal Stem Cells of Diverse Origins Support Persistent Infection with Kaposi's Sarcoma-Associated Herpesvirus and Manifest Distinct Angiogenic, Invasive, and Transforming Phenotypes | Q36548258 | ||
| Kaposi's sarcoma-associated herpesvirus encodes a mimic of cellular miR-23 | Q37252707 | ||
| SNPs in human miRNA genes affect biogenesis and function | Q37344542 | ||
| Kaposi's sarcoma herpesvirus (KSHV) microRNA K12-1 functions as an oncogene by activating NF-κB/IL-6/STAT3 signaling | Q37362933 | ||
| Genomewide mapping and screening of Kaposi's sarcoma-associated herpesvirus (KSHV) 3' untranslated regions identify bicistronic and polycistronic viral transcripts as frequent targets of KSHV microRNAs | Q37547788 | ||
| Kaposi's Sarcoma-Associated Herpesvirus MicroRNAs Target GADD45B To Protect Infected Cells from Cell Cycle Arrest and Apoptosis | Q37593234 | ||
| Humanized-BLT mouse model of Kaposi's sarcoma-associated herpesvirus infection | Q37612729 | ||
| HITS-CLIP and PAR-CLIP advance viral miRNA targetome analysis | Q38221158 | ||
| The impact of miRNA target sites in coding sequences and in 3'UTRs | Q38336299 | ||
| Tandem array-based expression screens identify host mRNA targets of virus-encoded microRNAs | Q38357974 | ||
| A Toolbox for Herpesvirus miRNA Research: Construction of a Complete Set of KSHV miRNA Deletion Mutants | Q38745770 | ||
| Identification of Target Genes Regulated by KSHV miRNAs in KSHV-Infected Lymphoma Cells | Q38913323 | ||
| A Kaposi's sarcoma-associated herpesvirus microRNA and its variants target the transforming growth factor β pathway to promote cell survival | Q39292510 | ||
| Construction and manipulation of a new Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome clone | Q39323923 | ||
| Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis | Q39683622 | ||
| Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay | Q39711736 | ||
| KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming | Q39751014 | ||
| Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: an evolutionary adaptation that fine-tunes lytic reactivation | Q39763904 | ||
| Distance constraints between microRNA target sites dictate efficacy and cooperativity | Q40153700 | ||
| Expression and function of microRNAs encoded by Kaposi's sarcoma-associated herpesvirus | Q40155119 | ||
| Conservation of virally encoded microRNAs in Kaposi sarcoma--associated herpesvirus in primary effusion lymphoma cell lines and in patients with Kaposi sarcoma or multicentric Castleman disease | Q40177470 | ||
| The expression profiles of microRNAs in Kaposi's sarcoma | Q41722433 | ||
| MicroRNA expression profiles in Kaposi's sarcoma | Q42270358 | ||
| P433 | issue | 8 | |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 648-661 | |
| P577 | publication date | 2017-03-02 | |
| P1433 | published in | Trends in Microbiology | Q15265732 |
| P1476 | title | KSHV microRNAs: Tricks of the Devil | |
| P478 | volume | 25 |
| Q30152630 | A viral microRNA downregulates metastasis suppressor CD82 and induces cell invasion and angiogenesis by activating the c-Met signaling |
| Q64102452 | Arachidonic Acid Derived Lipid Mediators Influence Kaposi's Sarcoma-Associated Herpesvirus Infection and Pathogenesis |
| Q59358229 | Cancer Progression Goes Viral: The Role of Oncoviruses in Aggressiveness of Malignancies |
| Q90702448 | Epigenetic control in Kaposi sarcoma-associated herpesvirus infection and associated disease |
| Q55395192 | Experience with Kaposi Sarcoma Herpesvirus Inflammatory Cytokine Syndrome in a Large Urban HIV Clinic in the United States: Case Series and Literature Review. |
| Q47290411 | Generation of a KSHV K13 deletion mutant for vFLIP function study. |
| Q92376588 | Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication Interferes with mTORC1 Regulation of Autophagy and Viral Protein Synthesis |
| Q64258840 | MicroRNA and Nonsense Transcripts as Putative Viral Evasion Mechanisms |
| Q55491581 | MicroRNA-Related Polymorphisms in Infectious Diseases-Tiny Changes With a Huge Impact on Viral Infections and Potential Clinical Applications. |
| Q40123168 | Profiling of cellular microRNA responses during the early stages of KSHV infection. |
| Q55338587 | Role of Pattern Recognition Receptors in KSHV Infection. |
| Q92373604 | Specific Inhibition of Viral MicroRNAs by Carbon Dots-Mediated Delivery of Locked Nucleic Acids for Therapy of Virus-Induced Cancer |
| Q58766247 | The Diverse Roles of microRNAs at the Host⁻Virus Interface |
| Q64247511 | Towards Better Understanding of KSHV Life Cycle: from Transcription and Posttranscriptional Regulations to Pathogenesis |
| Q89597918 | Viral miRNAs as Active Players and Participants in Tumorigenesis |
| Q64914433 | kshv-mir-k12-1-5p promotes cell growth and metastasis by targeting SOCS6 in Kaposi's sarcoma cells. |
| Q47099548 | miRNA-36 inhibits KSHV, EBV, HSV-2 infection of cells via stifling expression of interferon induced transmembrane protein 1 (IFITM1). |
| Q92878849 | miRNAs and their roles in KSHV pathogenesis |
Search more.